Why the study?
Is NOAC therapy safe and effective during the first 45 days after interventional LAA closure with the Watchman device?
Is NOAC therapy safe and effective during the first 45 days after interventional LAA closure with the Watchman device?
Initial pilot data suggests NOACs are a safe and effective alternative for short-term anticoagulation immediately following Watchman LAA closure.
Should not yet change post-LAA closure anticoagulation; hypothesis-generating for randomized trials of early NOAC use.
Our pilot study suggests that NOAC therapy within the first 45 days after interventional LAA closure is safe and effective.
No takes yet. Share an insight, caveat, or question.
Bösche et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: